Maintenance of therapeutic concentrations of caspofungin after temporary treatment interruption (48 hours) in a child with invasive aspergillosis

Antimicrob Agents Chemother. 2007 Oct;51(10):3775. doi: 10.1128/AAC.00890-07. Epub 2007 Jul 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antifungal Agents / administration & dosage*
  • Antifungal Agents / pharmacokinetics
  • Antifungal Agents / therapeutic use*
  • Aspergillosis / drug therapy*
  • Aspergillosis / microbiology
  • Caspofungin
  • Chromatography, High Pressure Liquid
  • Echinocandins / administration & dosage*
  • Echinocandins / pharmacokinetics
  • Echinocandins / therapeutic use*
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Humans
  • Leukemia, Myeloid, Acute / complications
  • Lipopeptides

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Caspofungin